Skip to Content

Cancers, Volume 16, Issue 5

2024 March-1 - 235 articles

Cover Story: Most platforms used to reconstruct the tumor ecosystem (TE) fail to explore the spatial context in the three-dimensional (3D) space of a solid tumor with single-cell resolution, and thus lack information on cell–cell or cell–extracellular matrix interactions. Our study features a pipeline of integrated multiplex multi-omics 3D spatially resolved modalities using two FFPE gynecological tumor samples. The multi-omics modalities include non-targeted mass spectrometry imaging, stereo-seq, and targeted seqIF. These spatially resolved modalities identify analytes in voxels across serial tissue sections, which reveals an integrated 3D spatial map displaying cell identity, activation, and energized status. These methods will provide insights into the molecular basis of spatial cell heterogeneity. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (235)

  • Article
  • Open Access
4 Citations
2,497 Views
9 Pages

The Combined Use of Inflammation Markers, Modified Glasgow Prognostic Score, and Sarculator Nomogram in Extremity Soft Tissue Sarcoma: A Multicenter Observational Study

  • Tomoki Nakamura,
  • Satoshi Takenaka,
  • Hidetatsu Outani,
  • Tomohito Hagi,
  • Hironari Tamiya,
  • Yoshinori Imura,
  • Kunihiro Asanuma and
  • Akihiro Sudo

6 March 2024

Background: Sarculator is a validated nomogram designed to predict overall survival (OS) in extremity soft tissue sarcoma (STS). Inflammation plays a critical role in cancer development and progression. There were no reports which investigated the re...

(This article belongs to the Special Issue Advances in Diagnosis and Treatment for Bone and Soft Tissue Sarcoma)
  • Review
  • Open Access
15 Citations
6,542 Views
13 Pages

The Convergence of Radiology and Genomics: Advancing Breast Cancer Diagnosis with Radiogenomics

  • Demetra Demetriou,
  • Zarina Lockhat,
  • Luke Brzozowski,
  • Kamal S. Saini,
  • Zodwa Dlamini and
  • Rodney Hull

6 March 2024

Despite significant progress in the prevention, screening, diagnosis, prognosis, and therapy of breast cancer (BC), it remains a highly prevalent and life-threatening disease affecting millions worldwide. Molecular subtyping of BC is crucial for pred...

(This article belongs to the Special Issue Imaging in Breast Cancer Diagnosis and Treatment)
  • Article
  • Open Access
1 Citations
2,837 Views
13 Pages

Longitudinal Muscle Biopsies Reveal Inter- and Intra-Subject Variability in Cancer Cachexia: Paving the Way for Biopsy-Guided Tailored Treatment

  • Panagiotis Filis,
  • Nikolaos P. Tzavellas,
  • Dimitrios Stagikas,
  • Christianna Zachariou,
  • Panagiotis Lekkas,
  • Dimitrios Kosmas,
  • Evangelia Dounousi,
  • Ioannis Sarmas,
  • Evangelia Ntzani and
  • Dimitrios Peschos
  • + 4 authors

6 March 2024

In the rapidly evolving landscape of cancer cachexia research, the development and refinement of diagnostic and predictive biomarkers constitute an ongoing challenge. This study aims to introduce longitudinal muscle biopsies as a potential framework...

(This article belongs to the Special Issue Advances in Cancer Cachexia)
  • Review
  • Open Access
16 Citations
5,283 Views
15 Pages

Current and Emerging Radiotherapy Options for Uveal Melanoma

  • Oleksii Semeniuk,
  • Esther Yu and
  • Mark J. Rivard

6 March 2024

What treatment options are there for patients having uveal melanoma? A randomized, prospective, multi-institutional clinical trial (COMS) showed no difference in survival between brachytherapy and enucleation for medium-sized lesions. With the obviou...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
8 Citations
4,572 Views
15 Pages

Onward Spread from Liver Metastases Is a Major Cause of Multi-Organ Metastasis in a Mouse Model of Metastatic Colon Cancer

  • Liza A. Wijler,
  • Bastiaan J. Viergever,
  • Esther Strating,
  • Susanne J. van Schelven,
  • Susanna Poghosyan,
  • Nicola C. Frenkel,
  • Hedy te Rietmole,
  • Andre Verheem,
  • Danielle A. E. Raats and
  • Onno Kranenburg
  • + 2 authors

6 March 2024

Colorectal cancer metastasizes predominantly to the liver but also to the lungs and the peritoneum. The presence of extra-hepatic metastases limits curative (surgical) treatment options and is associated with very poor survival. The mechanisms govern...

(This article belongs to the Topic Advances in Colorectal Cancer Therapy)
  • Article
  • Open Access
1 Citations
4,015 Views
17 Pages

Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States

  • Collin A. Sitler,
  • Chunqiao Tian,
  • Chad A. Hamilton,
  • Michael T. Richardson,
  • John K. Chan,
  • Daniel S. Kapp,
  • Charles A. Leath,
  • Yovanni Casablanca,
  • Christina Washington and
  • Kathleen M. Darcy
  • + 8 authors

6 March 2024

Purpose: To investigate IMT use and survival in real-world stage IVB cervical cancer patients outside randomized clinical trials. Methods: Patients diagnosed with stage IVB cervical cancer during 2013–2019 in the National Cancer Database and tr...

(This article belongs to the Special Issue Cervical Cancer: Screening and Treatment in 2024-2025)
  • Article
  • Open Access
7 Citations
4,228 Views
17 Pages

The Impact of Mutational Hotspots on Cancer Survival

  • Melissa Gonzalez-Cárdenas and
  • Víctor Treviño

6 March 2024

Background: Cofactors, biomarkers, and the mutational status of genes such as TP53, EGFR, IDH1/2, or PIK3CA have been used for patient stratification. However, many genes exhibit recurrent mutational positions known as hotspots, specifically linked t...

(This article belongs to the Special Issue Cancer Biomarkers: Recent Progress, Innovations and Future Clinical Implications)
  • Article
  • Open Access
5 Citations
2,943 Views
12 Pages

Robotic Complete ALPPS (rALPPS)—First German Experiences

  • Jörg Arend,
  • Mareike Franz,
  • Alexander Rose,
  • Christine March,
  • Mirhasan Rahimli,
  • Aristotelis Perrakis,
  • Eric Lorenz and
  • Roland Croner

6 March 2024

Background: ALPPS leads to fast and effective liver hypertrophy. This enables the resection of extended tumors. Conventional ALPPS is associated with high morbidity and mortality. MILS reduces morbidity and the robot adds technical features that make...

(This article belongs to the Section Methods and Technologies Development)
  • Article
  • Open Access
3 Citations
2,910 Views
13 Pages

CA9, CYFIP2 and LGALS3BP—A Novel Biomarker Panel to Aid Prognostication in Glioma

  • Amanda L. Hudson,
  • Angela Cho,
  • Emily K. Colvin,
  • Sarah A. Hayes,
  • Helen R. Wheeler and
  • Viive M. Howell

6 March 2024

Brain cancer is a devastating and life-changing disease. Biomarkers are becoming increasingly important in addressing clinical issues, including in monitoring tumour progression and assessing survival and treatment response. The goal of this study wa...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
5 Citations
2,937 Views
27 Pages

6 March 2024

Breast cancer (BrC) is a highly prevalent tumour among women. The high incidence and mortality rate of BrC prompts researchers to search for new markers that will provide information on the possible impact of the therapy on the risk of cancer-related...

(This article belongs to the Special Issue Research on Early-Stage Breast Cancer: Management and Treatment)
  • Article
  • Open Access
2 Citations
3,290 Views
16 Pages

Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma

  • Niki M. Zacharias,
  • Luis Segarra,
  • Keiko Akagi,
  • Natalie Wall Fowlkes,
  • Huiqin Chen,
  • Angelita Alaniz,
  • Carolyn de la Cerda,
  • Pedro Pesquera,
  • Yuanxin Xi and
  • Curtis A. Pettaway
  • + 5 authors

6 March 2024

Metastatic penile squamous cell carcinoma (PSCC) has only a 50% response rate to first-line combination chemotherapies and there are currently no targeted-therapy approaches. Therefore, we have an urgent need in advanced-PSCC treatment to find novel...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
6 Citations
4,256 Views
14 Pages

Electroporation in Translational Medicine: From Veterinary Experience to Human Oncology

  • Enrico P. Spugnini,
  • Maria Condello,
  • Stefania Crispi and
  • Alfonso Baldi

6 March 2024

Electroporation (EP) is a broadly accepted procedure that, through the application of electric pulses with appropriate amplitudes and waveforms, promotes the delivery of anticancer molecules in various oncology therapies. EP considerably boosts the a...

(This article belongs to the Special Issue Advanced Research in Oncology in 2023)
  • Correction
  • Open Access
1 Citations
1,555 Views
2 Pages
  • Article
  • Open Access
15 Citations
3,626 Views
11 Pages

Artificial-Intelligence-Assisted Detection of Metastatic Colorectal Cancer Cells in Ascitic Fluid

  • Hyung Kyung Kim,
  • Eunkyung Han,
  • Jeonghyo Lee,
  • Kwangil Yim,
  • Jamshid Abdul-Ghafar,
  • Kyung Jin Seo,
  • Jang Won Seo,
  • Gyungyub Gong,
  • Nam Hoon Cho and
  • Yosep Chong
  • + 2 authors

5 March 2024

Ascites cytology is a cost-effective test for metastatic colorectal cancer (CRC) in the abdominal cavity. However, metastatic carcinoma of the peritoneum is difficult to diagnose based on biopsy findings, and ascitic aspiration cytology has a low sen...

(This article belongs to the Special Issue Artificial Intelligence in Cancer Screening)
  • Article
  • Open Access
23 Citations
7,593 Views
15 Pages

High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer

  • Tomonori Tanei,
  • Shigeto Seno,
  • Yoshiaki Sota,
  • Takaaki Hatano,
  • Yuri Kitahara,
  • Kaori Abe,
  • Nanae Masunaga,
  • Masami Tsukabe,
  • Tetsuhiro Yoshinami and
  • Kenzo Shimazu
  • + 3 authors

5 March 2024

Purpose: Breast cancer tumors frequently have intratumoral heterogeneity (ITH). Tumors with high ITH cause therapeutic resistance and have human epidermal growth factor receptor 2 (HER2) heterogeneity in response to HER2-targeted therapies. This stud...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
9 Citations
2,888 Views
10 Pages

Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy

  • Gürkan Güner,
  • Levent Özçakar,
  • Yusuf Baytar,
  • Mehmet Ruhi Onur,
  • Metin Demir,
  • Burak Yasin Aktaş,
  • Oktay Halit Aktepe,
  • Deniz Can Güven,
  • Hakan Taban and
  • Ömer Dizdar
  • + 4 authors

5 March 2024

The objective of this study was to explore the possible association between low skeletal muscle mass (SMM)—assessed by computed tomography (CT) and ultrasound (US)—and hematologic toxicity in cancer patients. A prospective cohort study wa...

(This article belongs to the Special Issue Advances in Supportive and Palliative Care in Cancer)
  • Review
  • Open Access
7 Citations
5,087 Views
21 Pages

The Potential Influence of Residual or Recurrent Disease on Bevacizumab Treatment Efficacy in Ovarian Cancer: Current Evidence and Future Perspectives

  • Klaudia Żak,
  • Małgorzata Satora,
  • Ilona Skrabalak,
  • Rafał Tarkowski,
  • Marta Ostrowska-Leśko and
  • Marcin Bobiński

5 March 2024

There were high hopes for the new antiangiogenic medicament, bevacizumab, which could inhibit the creation of new blood vessels through binding to isoform A of vascular endothelial growth factor (VEGF). However, it is not only blood vessels that are...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
3 Citations
3,394 Views
15 Pages

Identification of GB3 as a Novel Biomarker of Tumor-Derived Vasculature in Neuroblastoma Using a Stiffness-Based Model

  • Aranzazu Villasante,
  • Josep Corominas,
  • Clara Alcon,
  • Andrea Garcia-Lizarribar,
  • Jaume Mora,
  • Monica Lopez-Fanarraga and
  • Josep Samitier

5 March 2024

Neuroblastoma (NB) is a childhood cancer in sympathetic nervous system cells. NB exhibits cellular heterogeneity, with adrenergic and mesenchymal states displaying distinct tumorigenic potentials. NB is highly vascularized, and blood vessels can form...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
3 Citations
3,090 Views
16 Pages

5 March 2024

Background: An atypical teratoid/rhabdoid tumor (AT/RT) is an uncommon and aggressive pediatric central nervous system neoplasm. However, a universal clinical consensus or reliable prognostic evaluation system for this malignancy is lacking. Our stud...

(This article belongs to the Section Pediatric Oncology)
  • Review
  • Open Access
10 Citations
4,543 Views
15 Pages

5 March 2024

Hepatocellular carcinoma (HCC), a prevalent and often fatal liver cancer, presents significant treatment challenges, especially in its advanced stages. This article delves into the promising approach of combining immunotherapy, particularly immune ch...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
28 Citations
27,062 Views
19 Pages

Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention

  • Hayato Muranaka,
  • Rasaq Akinsola,
  • Sandrine Billet,
  • Stephen J. Pandol,
  • Andrew E. Hendifar,
  • Neil A. Bhowmick and
  • Jun Gong

5 March 2024

Glutamine, a multifaceted nonessential/conditionally essential amino acid integral to cellular metabolism and immune function, holds pivotal importance in the landscape of cancer therapy. This review delves into the intricate dynamics surrounding bot...

(This article belongs to the Special Issue Pre-Clinical Studies of Personalized Medicine for Cancer Research)
  • Review
  • Open Access
21 Citations
6,765 Views
15 Pages

Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib

  • Junyeol Kim,
  • Tae Seung Lee,
  • Myeong Hwan Lee,
  • In Rae Cho,
  • Ji Kon Ryu,
  • Yong-Tae Kim,
  • Sang Hyub Lee and
  • Woo Hyun Paik

5 March 2024

Pancreatic cancer is characterized by fibrosis/desmoplasia in the tumor microenvironment, which is primarily mediated by pancreatic stellate cells and cancer-associated fibroblasts. HGF/c-MET signaling, which is instrumental in embryonic development...

(This article belongs to the Section Tumor Microenvironment)
  • Article
  • Open Access
9 Citations
4,498 Views
11 Pages

Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients

  • Andrea J. Haddad,
  • Ray Y. Hachem,
  • Mohamed Moussa,
  • Ying Jiang,
  • Hiba R. Dagher,
  • Patrick Chaftari,
  • Anne-Marie Chaftari and
  • Issam I. Raad

5 March 2024

Background: Nirmatrelvir/Ritonavir has been shown to reduce the risk of COVID-19 progression by 88% compared to placebo, while Molnupiravir reduced it by 31%. However, these two agents have not been compared head-to-head. We therefore compared the sa...

(This article belongs to the Special Issue Cancer Therapy: Where We Are and Where We Need to Go)
  • Article
  • Open Access
5 Citations
1,994 Views
15 Pages

Study International Multicentric Pancreatic Left Resections (SIMPLR): Does Surgical Approach Matter?

  • Sara Acciuffi,
  • Mohammed Abu Hilal,
  • Clarissa Ferrari,
  • Sara Al-Madhi,
  • Marc-Anthony Chouillard,
  • Nouredin Messaoudi,
  • Roland S. Croner and
  • Andrew A. Gumbs

5 March 2024

Background: Minimally invasive surgery is increasingly preferred for left-sided pancreatic resections. The SIMPLR study aims to compare open, laparoscopic, and robotic approaches using propensity score matching analysis. Methods: This study included...

(This article belongs to the Special Issue Clinical Surgery for Hepato-Pancreato-Biliary (HPB) Cancer)
  • Article
  • Open Access
1 Citations
3,701 Views
22 Pages

Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)

  • Sonja Aho,
  • Emerik Osterlund,
  • Ari Ristimäki,
  • Lasse Nieminen,
  • Jari Sundström,
  • Markus J. Mäkinen,
  • Teijo Kuopio,
  • Soili Kytölä,
  • Annika Ålgars and
  • Pia Osterlund
  • + 16 authors

5 March 2024

The primary tumor location (PTL) is associated with the phenotype, metastatic sites, mutations, and outcomes of metastatic colorectal cancer (mCRC) patients, but this has mostly been studied according to sidedness (right vs. left sided). We studied r...

(This article belongs to the Special Issue Advance in Colorectal Cancer: A Themed Issue in Honor of Prof. Bengt Glimelius)
  • Editorial
  • Open Access
1 Citations
2,252 Views
3 Pages

5 March 2024

The landscape of hepatocellular carcinoma (HCC) treatment has expanded significantly with the advent of multi-kinase inhibitors and immune checkpoint inhibitors [...]

(This article belongs to the Special Issue Hepatocellular Carcinoma: Current Treatment Strategies for Advanced Disease and Recurrence)
  • Editorial
  • Open Access
2,144 Views
4 Pages

5 March 2024

Prostate cancer, the most common cancer among males, has a mortality rate of approximately 29,000 deaths each year in the United States alone [...]

(This article belongs to the Section Tumor Microenvironment)
  • Article
  • Open Access
3 Citations
3,794 Views
15 Pages

Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts

  • Faizal Z. Asumda,
  • Nellie A. Campbell,
  • Mohamed A. Hassan,
  • Reza Fathi,
  • Daniella F. Vasquez Rico,
  • Melanie Kiem,
  • Ethan V. Vang,
  • Yo Han Kim,
  • Xin Luo and
  • Lewis R. Roberts
  • + 11 authors

5 March 2024

Upamostat is an orally available small-molecule serine protease inhibitor that is a highly potent inhibitor of trypsin 1, trypsin 2, trypsin 3 (PRSS1/2/3), and the urokinase-type plasminogen activator (uPA). These enzymes are expressed in many cancer...

(This article belongs to the Special Issue Current Epidemiologic, Diagnostic, and Therapeutic Aspects of Cholangiocarcinoma (CCA))
  • Article
  • Open Access
13 Citations
6,441 Views
13 Pages

Palliative Quad Shot Radiation Therapy with or without Concurrent Immune Checkpoint Inhibition for Head and Neck Cancer

  • Rituraj Upadhyay,
  • Emile Gogineni,
  • Glenis Tocaj,
  • Sung J. Ma,
  • Marcelo Bonomi,
  • Priyanka Bhateja,
  • David J. Konieczkowski,
  • Sujith Baliga,
  • Darrion L. Mitchell and
  • Dukagjin M. Blakaj
  • + 5 authors

5 March 2024

Objectives: Patients with recurrent and metastatic head and neck cancer (HNC) have limited treatment options. ‘QuadShot’ (QS), a hypofractionated palliative radiotherapy regimen, can provide symptomatic relief and local control and may po...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
5 Citations
3,939 Views
22 Pages

Increased O-GlcNAcylation by Upregulation of Mitochondrial O-GlcNAc Transferase (mOGT) Inhibits the Activity of Respiratory Chain Complexes and Controls Cellular Bioenergetics

  • Paweł Jóźwiak,
  • Joanna Oracz,
  • Angela Dziedzic,
  • Rafał Szelenberger,
  • Dorota Żyżelewicz,
  • Michał Bijak and
  • Anna Krześlak

5 March 2024

O-linked β-N-acetylglucosamine (O-GlcNAc) is a reversible post-translational modification involved in the regulation of cytosolic, nuclear, and mitochondrial proteins. The interplay between O-GlcNAcylation and phosphorylation is critical to cont...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
35 Citations
4,608 Views
9 Pages

Automatic 3D Augmented-Reality Robot-Assisted Partial Nephrectomy Using Machine Learning: Our Pioneer Experience

  • Alberto Piana,
  • Daniele Amparore,
  • Michele Sica,
  • Gabriele Volpi,
  • Enrico Checcucci,
  • Federico Piramide,
  • Sabrina De Cillis,
  • Giovanni Busacca,
  • Gianluca Scarpelli and
  • Michele Di Dio
  • + 5 authors

4 March 2024

The aim of “Precision Surgery” is to reduce the impact of surgeries on patients’ global health. In this context, over the last years, the use of three-dimensional virtual models (3DVMs) of organs has allowed for intraoperative guida...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
3 Citations
2,542 Views
19 Pages

4 March 2024

Glioblastoma multiforme (GBM) is the most common and deadly type of brain tumor originating from glial cells. Despite decades of clinical trials and research, there has been limited success in improving survival rates. However, molecular pathology st...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
28 Citations
4,206 Views
18 Pages

Monoclonal Antibodies for Targeted Fluorescence-Guided Surgery: A Review of Applicability across Multiple Solid Tumors

  • Stefano Giuliani,
  • Irene Paraboschi,
  • Angus McNair,
  • Myles Smith,
  • Kenneth S. Rankin,
  • Daniel S. Elson,
  • Vinidh Paleri,
  • Daniel Leff,
  • Graeme Stasiuk and
  • John Anderson

4 March 2024

This study aims to review the status of the clinical use of monoclonal antibodies (mAbs) that have completed or are in ongoing clinical trials for targeted fluorescence-guided surgery (T-FGS) for the intraoperative identification of the tumor margins...

(This article belongs to the Special Issue New Findings in Targeting Cancer Proteins)
  • Systematic Review
  • Open Access
15 Citations
4,170 Views
18 Pages

The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Cutaneous Oncology: A Systematic Review of Evidence beyond Malignant Melanoma

  • Konstantinos Seretis,
  • Konstantinos Sfaelos,
  • Elena Boptsi,
  • Georgios Gaitanis and
  • Ioannis D. Bassukas

4 March 2024

With the ongoing progress of basic research along with the introduction of new pharmaceutical options spanning almost all therapeutic areas, the need for biomarkers that will be implemented into the personalized medical approach is higher than ever....

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
3 Citations
2,014 Views
12 Pages

Impact of Pre-Liver Transplant Treatments on the Imaging Accuracy of HCC Staging and Their Influence on Outcomes

  • Eloisa Franchi,
  • Daniele Eliseo Dondossola,
  • Giulia Maria Francesca Marini,
  • Massimo Iavarone,
  • Luca Del Prete,
  • Clara Di Benedetto,
  • Maria Francesca Donato,
  • Barbara Antonelli,
  • Pietro Lampertico and
  • Lucio Caccamo

4 March 2024

The outcome of liver transplantation (LT) for hepatocarcinoma (HCC) is strongly influenced by HCC staging, which is based on radiological examinations in a pre-LT setting; concordance between pre-LT radiological and definitive pathological staging re...

(This article belongs to the Special Issue New Insights on Therapy in Hepatocellular Carcinoma)
  • Article
  • Open Access
18 Citations
4,111 Views
25 Pages

Dual Checkpoint Aptamer Immunotherapy: Unveiling Tailored Cancer Treatment Targeting CTLA-4 and NKG2A

  • Mohamad Ammar Ayass,
  • Trivendra Tripathi,
  • Natalya Griko,
  • Tutku Okyay,
  • Ramya Ramankutty Nair,
  • Jin Zhang,
  • Kevin Zhu,
  • Kristen Melendez,
  • Victor Pashkov and
  • Lina Abi-Mosleh

4 March 2024

Recent strides in immunotherapy have illuminated the crucial role of CTLA-4 and PD-1/PD-L1 pathways in contemporary oncology, presenting both promises and challenges in response rates and adverse effects. This study employs a computational biology to...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Editorial
  • Open Access
2 Citations
2,534 Views
5 Pages

4 March 2024

The history of thymoma (TH) research begins in the early 20th century, when Bell first recognized the epithelial nature of these tumors and their association with myasthenia gravis (MG) [...]

(This article belongs to the Special Issue Thymic Tumors: New Developments and Future Directions in Molecularly Informed Therapies)
  • Article
  • Open Access
4 Citations
2,320 Views
13 Pages

A Joint Model Based on Post-Treatment Longitudinal Prognostic Nutritional Index to Predict Survival in Nasopharyngeal Carcinoma

  • Po-Wen Hsiao,
  • Yu-Ming Wang,
  • Shao-Chun Wu,
  • Wei-Chih Chen,
  • Ching-Nung Wu,
  • Tai-Jan Chiu,
  • Yao-Hsu Yang and
  • Sheng-Dean Luo

3 March 2024

Background: a low PNI in patients with NPC is linked to poor survival, but prior studies have focused on single-timepoint measurements. Our study aims to employ joint modeling to analyze longitudinal PNI data from each routine visit, exploring its re...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
10 Citations
11,323 Views
12 Pages

3 March 2024

Endoscopy is mandatory to detect early gastric cancer (EGC). When considering the cost-effectiveness of the endoscopic screening of EGC, risk stratification by combining serum pepsinogen values and anti-H. pylori IgG antibody values is very promising...

(This article belongs to the Special Issue Gastric Cancer: Evolving Landscape and Emerging Therapies)
  • Article
  • Open Access
1 Citations
2,700 Views
16 Pages

3 March 2024

The aim of this study is to assess mortality trends due to malignant neoplasms of female genital organs (MNFGOs) in Poland between 2000 and 2021. For the purpose of the study, the authors used data on all deaths of Polish female inhabitants due to MN...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Article
  • Open Access
2 Citations
2,320 Views
14 Pages

Usefulness of Body Position Change during Local Ablation Therapies for the High-Risk Location Hepatocellular Carcinoma

  • Hitomi Takada,
  • Yasuyuki Komiyama,
  • Leona Osawa,
  • Masaru Muraoka,
  • Yuichiro Suzuki,
  • Mitsuaki Sato,
  • Shoji Kobayashi,
  • Takashi Yoshida,
  • Shinichi Takano and
  • Nobuyuki Enomoto
  • + 1 author

3 March 2024

Local ablation therapies are important treatment options for early-stage hepatocellular carcinoma (HCC). Various techniques have been used to perform these therapies efficiently and safely. However, few reports have discussed the usefulness of body p...

(This article belongs to the Special Issue Current Role of Ablation in Liver Cancer Therapy)
  • Article
  • Open Access
7 Citations
3,721 Views
23 Pages

A Comprehensive Understanding of Post-Translational Modification of Sox2 via Acetylation and O-GlcNAcylation in Colorectal Cancer

  • Yoojeong Seo,
  • Dong Keon Kim,
  • Jihye Park,
  • Soo Jung Park,
  • Jae Jun Park,
  • Jae Hee Cheon and
  • Tae Il Kim

3 March 2024

Aberrant expression of the pluripotency-associated transcription factor Sox2 is associated with poor prognosis in colorectal cancer (CRC). We investigated the regulatory roles of major post-translational modifications in Sox2 using two CRC cell lines...

(This article belongs to the Special Issue Targeted Therapy in Gastrointestinal Cancer)
  • Article
  • Open Access
7 Citations
3,697 Views
16 Pages

A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL)

  • Natividad Martínez-Banaclocha,
  • Francisca Martínez-Madueño,
  • Berta Caballé,
  • Joan Badia,
  • Mar Blanes,
  • David Aguiar Bujanda,
  • Virginia Calvo,
  • Jose Gómez Codina,
  • Cristina Quero Blanco and
  • Josep Gumà
  • + 7 authors

3 March 2024

Primary cutaneous B-cell lymphomas (PCBCLs) are B-cell lymphomas that can occur in the skin without evidence of extracutaneous involvement. The 2005 WHO/EORTC classification of cutaneous lymphomas and its 2018 update have distinguished three main cat...

(This article belongs to the Section Cancer Pathophysiology)
  • Review
  • Open Access
9 Citations
2,948 Views
16 Pages

Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple Myeloma

  • Maciej Dubaj,
  • Karol Bigosiński,
  • Aleksandra Dembowska,
  • Radosław Mlak,
  • Aneta Szudy-Szczyrek,
  • Teresa Małecka-Massalska and
  • Iwona Homa-Mlak

2 March 2024

Multiple myeloma (MM) is the second most common hematologic malignancy in the world and accounts for 15% of primary hemocytopathies, with an ever-increasing number of new cases. It is asymptomatic in 30% of instances; hence, the determination of high...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
34 Citations
15,121 Views
32 Pages

2 March 2024

The United States Food and Drug Administration (FDA) has approved a plethora of peptide-based drugs as effective drugs in cancer therapy. Peptides possess high specificity, permeability, target engagement, and a tolerable safety profile. They exhibit...

(This article belongs to the Section Cancer Drug Development)
  • Review
  • Open Access
12 Citations
6,697 Views
11 Pages

Current Status and Future Directions of Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer

  • Nicholas Eustace,
  • Jason Liu,
  • Colton Ladbury,
  • Andrew Tam,
  • Scott Glaser,
  • An Liu and
  • Yi-Jen Chen

2 March 2024

Purpose: The standard of care for patients with locally advanced cervical cancer is definitive chemoradiation followed by a brachytherapy boost. This review describes the current status and future directions of image-guided adaptive brachytherapy for...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
11 Citations
5,298 Views
15 Pages

2 March 2024

Hepatocellular carcinoma (HCC) is diagnosed annually in nearly a million people worldwide, with approximately half of them being diagnosed at an advanced stage of the disease. Non-infectious risk factors for the development of HCC include an unbalanc...

(This article belongs to the Special Issue Advances in the Prevention and Treatment of Liver Cancer)
  • Review
  • Open Access
70 Citations
17,975 Views
19 Pages

2 March 2024

Colorectal cancer (CRC) is the second-leading cause of cancer-related mortality worldwide. CRC mortality results almost exclusively from metastatic disease (mCRC) for which systemic chemotherapy is often a preferred therapeutic option. Biomarker-base...

(This article belongs to the Special Issue Novel Strategies in the Prevention/Treatment of Colorectal Cancer)
  • Review
  • Open Access
83 Citations
16,406 Views
14 Pages

1 March 2024

Endometrial cancer is the sixth commonest cancer in women worldwide, with over 417,000 diagnoses in 2020. The disease incidence has increased by 132% over the last 30 years and is set to continue to rise in response to an ageing population and increa...

(This article belongs to the Section Cancer Epidemiology and Prevention)

of 5

XFacebookLinkedIn
Cancers - ISSN 2072-6694